Rare Disease Trial, Recruiting (NCT06676046)

Rare Disease Trial, Recruiting NCT06676046 Sponsor: National Heart, Lung, and Blood Institute (NHLBI) Condition: Rare Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06676046 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Rare Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with a health condition:

You are aged 10 years or older
You have a confirmed or suspected rare disorder that causes unusual levels of fats (such as cholesterol or triglycerides) in your blood, or unusual patterns of fatty buildup in your arteries
You (or your legal representative) are able to understand and sign a consent form agreeing to take part

For healthy volunteers:

You are in good health with no known history of conditions affecting fat levels in your blood
You are not pregnant

Who may not be able to join:

You have a common condition (not a rare disorder) that causes abnormal fat or cholesterol levels in your blood
You have any other health findings that the lead doctor believes would make it unsafe or unsuitable for you to take part (confirm with trial site)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

This information is a simplified summary of the official criteria only. It is not medical advice, and whether you qualify can only be confirmed by the research team running the trial.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Marcelo J Amar, M.D., National Heart, Lung, and Blood Institute (NHLBI)

Phone: (301) 480-7632

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06676046

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Phase: Not Applicable

Status: Recruiting

Condition: Rare Disease

Trial contact: (301) 480-7632

More information: https://clinicaltrials.gov/study/NCT06676046

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

For people with a health condition:

You are aged 10 years or older
You have a confirmed or suspected rare disorder that causes unusual levels of fats (such as cholesterol or triglycerides) in your blood, or unusual patterns of fatty buildup in your arteries
You (or your legal representative) are able to understand and sign a consent form agreeing to take part

For healthy volunteers:

You are in good health with no known history of conditions affecting fat levels in your blood
You are not pregnant

Who may not be able to join:

You have a common condition (not a rare disorder) that causes abnormal fat or cholesterol levels in your blood
You have any other health findings that the lead doctor believes would make it unsafe or unsuitable for you to take part (confirm with trial site)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

This information is a simplified summary of the official criteria only. It is not medical advice, and whether you qualify can only be confirmed by the research team running the trial.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)

Registry

ClinicalTrials.gov

Start date

15 January 2025

Est. completion

24 November 2044

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change overtime in low-density lipoprotein cholesterol (LDL-C).

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov